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[Excerpt] The scope and scale of clinical research is unknown for any medical or surgical specialty 
beyond snap shots of the broad aims and expenditures of research programs sponsored by federal 
agencies or the pharmaceutical industry. As a consequence, the workforce and workplace for clinical 
investigation is enigmatic and unexamined even after explicit warnings that an essential arm for 
advancing clinical practice is disabled. The present study was designed to examine the nature and extent 
of investigative activity prevailing among rheumatologists early in their careers. This assessment 
provides a lens on: i) the fraction of early career rheumatologists who engage in investigative 
rheumatology, ii) the scope and scale of research in musculoskeletal diseases, iii) funding available for 
investigative work, iv) the impact of "research-intensive" institutions, and NIH-K-series awards on 
research, and v) the demographic backgrounds of early career rheumatologists. 
The results provide important new insights about the early career workforce for discovery and innovation 
in rheumatology. The findings integrate demographic, normative, and predictive data to provide the first 
estimate of the scope and scale of clinical investigation within rheumatology. The results also justify 
interventions for promoting investigative work, and ultimately advancing the clinical practice of 
rheumatology. 
Keywords 
rheumatologists, research, workplace, workforce 
Comments 
Suggested Citation 
Desjardins, C., St, Clair, E.W., & Ehrenberg, R.G. (2009). The scope and scale of clinical research 
accomplished by rheumatologists early in their careers [Electronic version]. Retrieved [insert date], from 
Cornell University, School of Industrial and Labor Relations site: http://digitalcommons.ilr.cornell.edu/
workingpapers/126/ 
Required Publisher Statement 
Published by the Cornell Higher Education Research Institute, Cornell University. 
This article is available at DigitalCommons@ILR: https://digitalcommons.ilr.cornell.edu/workingpapers/126 
  
 
The Scope and Scale of Clinical Research Accomplished by  
 
Rheumatologists Early in Their Careers 
 
 




     This research was supported, in part, by a grant from The American College of Rheumatology (ACR), 
Atlanta GA to defray the cost of producing and managing a web-based survey, and in part by the Cornell 
Higher Education Research Institute, Cornell University, Ithaca, NY. The ACR exercised no role in the 
design or analysis of this study, nor in the decision to publish the findings. The contents of this article are 
solely attributable to the authors, and do not reflect the views of ACR, any of its officers, or staff. 
     1Claude Desjardins, Ph.D., Clinical Scholars Project, CSN Building-M/C 955, University of Illinois 
Medical Center, 820 S. Wood Street, Chicago IL  60612-4325; 2E. William St. Clair, M.D., Division of 
Rheumatology and Immunology, Department of Medicine, Duke University, Box 3874 Medical Center, 
Durham, NC 27710, 3Ronald G. Ehrenberg, Ph.D., Cornell Higher Education Research Institute, 385A 
Ives East, Cornell University, Ithaca, NY  14853-3901. 
     Address for correspondence and reprint requests: Claude Desjardins, Clinical Scholars Project, CSN 






Objective. Assess the workforce and workplace for rheumatology, and the investigative work 
accomplished by rheumatologists early in their careers. 
Methods. "Early career rheumatologists" are defined as physicians who joined ACR between 1991-2005, 
were under 49 years of age on joining ACR, and reside in Canada or the US. This cohort was invited to 
respond to a web-based survey distributed by ACR. A total of 247 survey instruments (21.2 % response 
rate) were used for this study. Survey questions were designed to obtain core insights about: i) the 
workforce, ii) workplace, iii) time devoted to administrative, clinical service, didactic, and investigative 
tasks, iv) types of investigative work accomplished, v) sources of funding for training and research, and 
vi) a demographic profile of respondents. 
Results. Investigative work is pursued across all workplaces where rheumatologists are employed. 
Patient-oriented research predominates at 32 % followed by disease- and population-oriented studies at a 
respective 17 % and 13 %. Basic-, translational-, and prevention-oriented research was accomplished by a 
respective 9.6 %, 8.3 %, and 3.7 % of respondents. Clinical earnings underwrite about 40% of the salary 
costs for research, grants/contracts about 21.3%, and hospitals/medical schools about 14.5%. Completion 
of pre-and post-clinical training at "research-intensive" institutions is correlated with half-days/wk 
devoted to research (P < 0.01), and the receipt of a NIH K-08 grant is positively associated with receiving 
2.8 federal research-project grants (P < 0.001). Rheumatologists associate research with lost earnings, a 
perception validated by an estimated reduction in pre-tax annual earnings of 2.3% for each half-day/wk 
dedicated to research (P < 0.01). 
Conclusions. Over 80% of the early career workforce pursues investigative work, and human subjects are 
required for 90% of research projects. No measurable gender disparities were identified. Interventions are 
proposed to enhance the number of K-08 awardees; address disincentives for pursuing investigative work, 
recruit rheumatologists from underrepresented demographic groups, and improve funding within all 
domains of investigative rheumatology.  
     Clinical research commands a pivotal position in the overall structure of medicine for several reasons. 
First, and most important, clinical investigation is the proving ground for all innovations and discoveries 
that advance the practice of medicine. Second, clinical research serves as the training ground for 
producing the next generation of investigators needed to sustain medical progress. Third, a reward 
structure has evolved among clinical investigators leading to peer recognition, and the opportunity to 
obtain funds required for the production of a public good. In the case of rheumatologists, clinical 
investigation serves as the mechanism to advance clinical practice through the development of improved 
diagnostics, new treatments, and preventions that enhance the lives of the thousands of patients who 
suffer from a disorder occasioned by persistent pain and accumulated disability (1). 
     The scope and scale of clinical research is unknown for any medical or surgical specialty beyond snap 
shots of the broad aims and expenditures of research programs sponsored by federal agencies or the 
pharmaceutical industry (2-4). As a consequence, the workforce and workplace for clinical investigation 
is enigmatic and unexamined even after explicit warnings that an essential arm for advancing clinical 
practice is disabled (5-8). The present study was designed to examine the nature and extent of 
investigative activity prevailing among rheumatologists early in their careers. This assessment provides a 
lens on: i) the fraction of early career rheumatologists who engage in investigative rheumatology, ii) the 
scope and scale of research in musculoskeletal diseases, iii) funding available for investigative work, iv) 
the impact of "research-intensive" institutions, and NIH-K-series awards on research, and v) the 
demographic backgrounds of early career rheumatologists.  
      The results provide important new insights about the early career workforce for discovery and 
innovation in rheumatology. The findings integrate demographic, normative, and predictive data to 
provide the first estimate of the scope and scale of clinical investigation within rheumatology. The results 
also justify interventions for promoting investigative work, and ultimately advancing the clinical practice 
of rheumatology. 
MATERIALS AND METHODS 
     Survey participants. The American College of Rheumatology (ACR) is the primary professional 
organization (www.rheumatology.org) dedicated to advancing the clinical practice of rheumatology in 
North America. An agreement was established with ACR to distribute a web-based survey instrument---
produced by the authors---to e-mail addresses maintained by ACR. A letter of invitation from ACR 
preceded respondent access to the survey instrument. 
     Rheumatologists, early in their careers, were identified for this study based on four criteria: joined 
ACR between January 1, 1991 and December 31, 2005, earned an M.D. or equivalent degree, reside in 
Canada or the United States, and were under 49 yr of age on joining ACR. A screening question was 
asked to verify whether respondents held a license to practice medicine in Canada or the US. Unlicensed 
respondents were thanked and excluded from participating in the survey to limit the findings to physicians 
qualified to direct clinical protocols involving human subjects.  
     The cohort of early career rheumatologists designated for this survey received an original email, and 
two follow-up email reminders if they failed to return a survey instrument between December 2007 and 
February 2008. A copy of the survey tool is available at 
<http://www.cornellsurveyresearch.com/sri/files/Rheumatology_Questionnaire.pdf>. A total of 265 
rheumatologists accessed the hyperlink in the email message to participate in this study. Incomplete 
surveys were discarded making a total of 247 survey instruments available for assessment, and a final 
response rate of 21.2 %. The survey protocol adopted for this study is consistent with that used by ACR to 
survey members about services or issues pertaining to rheumatology.  The mean response rate for three 
ACR surveys accomplished in 2007-2008 was 25.7 % (9), a value that approximates the response rate 
achieved for this study. 
     Instructions to survey participants indicated that the distribution of the survey questionnaire was 
approved by the Board of Directors of ACR, and that IRB approval was obtained, for an exempt protocol, 
from the Office for the Protection of Research Subjects, 203 Administrative Office Building, University 
of Illinois at Chicago, Chicago, IL 60612 (www.research.uic.edu). Respondents were advised that 
participation was voluntary, confidentiality would be maintained, and that none of the research conducted 
or published would divulge the responses of individual physicians. Individual responses were submitted 
anonymously over the Internet. Survey security was maintained by directing responses over a secure 
server. Participant data, resided behind a firewall, on a secure server at the Survey Research Institute at 
Cornell University, Ithaca, NY (http://www.cornellsurveyresearch.com). 
       Design and content of survey instrument. A preliminary version of the survey instrument was 
tested for ambiguity and errors. A random sample of 50 rheumatologists, satisfying all "early career" 
criteria, was invited to respond to a draft version of the survey. Pilot survey participants were asked to 
comment on any question they perceived to be ambiguous, awkward, or impertinent. A total of 18 
participants returned pilot surveys with comments that were used to reformat the survey instrument used 
in this study. The results of pilot surveys are excluded from the final results presented here. 
      The final version of the survey instrument invited participants to identify their place of employment, 
specify the number of half-days/wk devoted to clinical service, teaching, research, and administrative 
activities based on their supervisor's expectations, or themselves in the case of solo practitioners, 
designate the source(s) of salary support for time spent on research, and indicate their annual pre-tax 
compensation within ordered ranges.  
     Respondents were asked to select one or more types of research that "best defined" their investigative 
work over the past 12 months. The menu of investigative activities---with definitions---included: Basic 
research: involves laboratory-based research including the development of new drugs, technologies, or 
devices. Translational research: entails bench to bedside or bi-directional research involving human 
subjects known to the investigator. Excludes the use of human specimens of cells/tissues for laboratory-
based studies. Disease-oriented research: requires the use of human subjects to investigate the 
mechanisms or natural history of diseases, or improve the detection or diagnosis of a disease. Patient-
oriented research: clinical trials, including Phase I, II, III, IV trials of drugs, and biologics, tests of 
devices, and the evaluation of therapeutic interventions. Population-oriented research: includes outcomes 
studies of populations, health services and cost effectiveness research, studies of health quality including 
best practices and medical errors, epidemiology and genetic studies, and community-based clinical trials. 
Prevention-oriented research: primary and secondary prevention of disease in patients, and health 
promotion via behavioral modification. 
     A series of positive and negative questions were asked to test commonly perceived disincentives for 
pursuing investigative work. This series of questions relied on a 4-point Likert scale (10). The scale was 
collapsed to limit the analysis to two outcomes: agree or disagree. A second series of questions was used 
to estimate the quality of institutional support available for clinical or laboratory research projects during 
residency and fellowship training. The third series of questions considered sources for funding available 
to rheumatologists who sought additional training to pursue investigative work. A final series of questions 
tested whether respondents submitted proposals and won grant/contract support for research projects in 
rheumatology either as a principle or as a co-principle investigator.  
     The demographic profile of rheumatologists, early in their careers, was examined by inviting 
respondents to designate their age, citizenship (Canada or US), gender, and ethnic origin. Other questions 
were used to identify the institutions where respondents earned their baccalaureate and medical degrees, 
where their residency and fellowship training was accomplished, and where they earned advanced 
degrees. 
       Analysis and interpretation of survey results. A unique case number was assigned to each survey 
instrument returned to the Survey Research Institute at Cornell University so individual responses would 
remain anonymous.  Case numbers were used to evaluate the responses to all questions, determine the 
total number of responses to individual questions, and estimate the statistical attributes of each answered 
question.  
     The fraction of respondents whose pre- and post-clinical training occurred in the United States was 
studied in detail to test whether or not statistical correlations exist between training at "research-intensive" 
institutions and the performance of investigative work as measured by half-days/wk devoted to research 
or the receipt of grants /contracts. The "research-intensity" of institutions where rheumatologists 
accomplished their pre- and post-clinical training in the United States were ranked as described next.  
     Institutions awarding baccalaureate degrees were assigned a program identification number designated 
by the Integrated Postsecondary Education Data System (IPEDS), Institute for Educational Statistics of 
the U.S. Department of Education (11). Unique identification numbers were assigned for colleges and 
universities with multiple campuses since admission criteria differ within multi-campus systems. Program 
identification numbers were used to establish the median SAT score of admitted or entering students from 
a database of 1,300 colleges and universities included in 2005 Annual Survey of Colleges (12). The 
median SAT score in this database is the midpoint of SAT scores falling within the 25th to 75th percentile 
range. This measure provides a reliable approximation of the median assuming that SAT scores within 
this range are not clumped at the endpoints for any given institution.  Median SAT scores for individual 
institutions were ordered from highest to lowest and divided into ten groups with near equivalent 
frequencies to rank U.S. colleges and universities awarding baccalaureate degrees on a scale from 10 to1 
with 10 assigned to the fraction of institutions with the highest median SAT scores.  Equal observations, 
“ties”, where assigned the average rank of the group. In a few instances, institutional SAT scores were 
unavailable and required the substitution of ACT for SAT scores. This transformation was achieved by 
converting the reported institutional ACT score into an SAT score using the algorithm established for this 
conversion and published by ACT (13).  
     A similar 10-point scale was developed to rank U. S. medical schools. The unique program 
identification numbers for each medical school relied on those assigned by the American Association of 
Medical Colleges (14). Medical school rank was based on total dollars awarded to the nations 126 
allopathic medical schools by the National Institutes of Health (NIH) for peer reviewed research 
grants/contracts (excluding awards for construction or training) funded in 1996, 2000, and 2005, 
respectively (15).  Residency programs in internal medicine and pediatrics, and fellowship programs in 
adult and pediatric rheumatology were assigned unique program identification numbers based on those 
designated by the Accreditation Council for Graduate Medical Education (ACGME, 16). All academic 
medical centers and teaching hospitals with approved residency and fellowship programs in rheumatology 
(internal medicine and pediatrics) were ranked on the previously described 10-point ordered scale, based 
on total dollars awarded to institutional program sponsors by the Department of Health and Human 
Services (HHS) for all agencies administering peer reviewed research grants/contracts (excluding 
construction or training awards) in 1996, 2000, and 2005, respectively (17). The ethnic backgrounds of 
allopathic medical school graduates in the United States were determined by estimating the mean 
distribution of each ethnic group reported for 1991 to 2005 from data compiled and published by the 
American Association of Medical Colleges (18). 
     Institutions awarding graduate degrees were assigned a unique program identification number 
designated by IPEDS (11). Graduate programs in the life sciences were ranked on a 10-ponit scale, 
previously described, using total federal obligations committed for research in the life sciences by both 
HHS and the National Science Foundation to 210 graduate institutions over three fiscal years: 1996, 2000, 
and 2005 (17). 
     Statistical methodology. Pearson’s chi-square goodness-of-fit-test was used to determine whether or 
not the cohort of survey respondents and the population of respondents eligible for this study differed 
based on the following criteria: gender mix, age distribution, fraction of residents from states within the 
US, and the distribution of residents from Canada or the US. The results involving multiple comparisons 
across groups relied on testing whether the distribution differed across groups or in the case of means, 
whether the means differed across or between groups. Data involving frequency statistics, such as yes/no 
responses and the distribution of men and women, are compared via Pearson’s chi-square goodness-of-fit-
test. Statistical assessments involving means rely on the analysis of variance, or a simple paired T-test for 
between group comparisons. 
     A multiple regression model was used to test the association between the receipt of research project 
grants by PI's and Co-PI's and other explanatory variables of research performance, and the  "research-
intensity" of each of the intuitions individual respondents attended for their baccalaureate, M.D. degree, 
residency, and fellowship. The probability of regression coefficients relies on the assumption that 
variables are distributed randomly. The assumptions underling the adoption of an unmodified ordinary 
least squares model include linearity, full rank, exogeneity of independent variables, homoscedasticity of 
error terms, and exogenously generated data. The results are reported as two-sided P-values with 
estimated confidence intervals. 
     We used a Tobit regression model to determine the association between pre-tax annual earnings and 
various outcome measures since this model accommodates the censored earnings that respondents 
reported within specified ranges. We tested dependent variables, with binary responses, using the logit 
regression model with the assumption that the natural log of the probability ratio is approximated by a 
linear function. Certain respondents failed to report the number of half-days spent on research, or provide 
information related to the submission of proposals for research project grants. The absence of a response, 
in a few cases, is assumed to be zero or identical to the no-responses entered by most respondents. We 
justified this transformation on the basis that rheumatologists who are unengaged in research would likely 
overlook the need to document a zero response. 





      Survey sample. This report is based on a cohort of 247 rheumatologists, early in their careers, who 
completed and returned survey questionnaires considered for this study. The cohort of actual respondents 
was compared with the sample of eligible participants to test whether or not the two groups differed on 
the basis of age, gender, state of residence, and country (Canada and United States). The results indicate 
that the four tested criteria were similar (P > 0.20) for the cohort of expected and actual respondents, 
evidence that the participants who took part in this study are representative of ACR members, early in 
their careers. 
     Pre- and post-clinical training in rheumatology. A significant number (P < 0.05) of early career 
rheumatologists completed their preclinical training outside of North America. The percent of respondents 
earning a baccalaureate degree from an institution in the US, Canada or an international location or was 
84.3 %, 5.2 %, and 10.5 % respectively. A respective 75.5 %, 4.6 %, and 19.9% of respondents earned an 
MD or equivalent degree from a US, Canadian, or international institution. Residency and fellowship 
training, as expected, was accomplished in North America with 98.6% of the respondents trained in 
Canada or the United States.  
     Respondents completed medical school at 27.1 ± 0.2 years of age (mean ± SEM) and finished 
fellowship training at an average of 33.7 ± 0.2 years, an elapsed interval of 6.6 ± 0.2 years. The mean age 
at which women and men concluded their pre-and post-clinical training was nearly identical. The results 
establish the lack of any significant gap in the time required to finish residency and fellowship programs 
in rheumatology, and document that early career rheumatologists enter the workforce at a mean age of 
33.7 years to provide clinical care or pursue clinical research or both. Further, about 99% of the 
respondents report that they are board certified or board eligible in either adult or pediatric rheumatology, 
an indication that the training of rheumatologists in this study was remarkably homogenous.   
     Demographic profile of rheumatologists.  The distribution of respondents residing in the United 
States and Canada was a respective 95% and 5%. The mean fraction of citizens, permanent residents, and 
non-citizen respondents from the United States was on the order of 85.8 %, 8.5 %, and 5.7 %, 
respectively. The fraction of citizens, permanent residents, and non-citizens among Canadian members of 
ACR was nearly identical to that of rheumatologists residing in the United States (P > 0.50). 
     The gender of early career participants, from the United States, was 44.8 % women and 55.2 % men. 
All other demographic measures  (age, gender, ethnic background) of respondents from the United Sates 
and Canada were similar (P > 0.50), an indication that the cohort of early career rheumatologists, from 
both countries, are indistinguishable for the purposes of this study. 
     The self-identified ethnic backgrounds of rheumatologists, early in their careers, is shown in Table 1 
for comparison with that of US medical school graduates over the same 15 year sample interval (1991-
2005) adopted for this study. The fraction of respondents from Asian and Hispanic or Latino backgrounds 
approaches that of US medical school graduates (Table 1). The number of Black or African American 
rheumatologists, in contrast, is underrepresented in the survey sample by about 6.5% while the number of 
Caucasians is overrepresented by the same amount, when compared with the population of students (mean 
of 15,713/yr) earning an M.D. degree in the 15-year interval between 1991 and 2005 (Table 1). 
     Workplace assessments. The amount of time early career rheumatologists spend on clinical service, 
teaching, research, and administrative work was estimated by asking respondents to specify the number of 
half-days/wk devoted to each activity based on the percent effort they negotiated with their supervisor in 
the immediate 12 months preceding the survey (Table 2). Respondents were cautioned exclude "off-the-
clock" work-related activities that might take place on evenings, weekends, or holidays. Thus, the results 
reflect the distribution of work accomplished by rheumatologists over a putative 40 hr workweek, the 
federal standard for reporting time/effort across all employment sectors in the US (Table 2). 
     The findings document that clinical service is accomplished across all workplaces where 
rheumatologists are employed (Table 2). Respondents employed in a solo or group practice, health 
system, or hospital, however, place a premium on providing clinical care as evidenced by an average 
commitment of about 7.9 half-days/wk. In sharp contrast, a respective 3.5, 2.3 and 1.5 half-days/wk are 
devoted to clinical service among rheumatologists employed in academic medical centers, the federal 
government, and the pharmaceutical/biotech industry (Table 2).  
     Early career rheumatologists, from all workplaces, are involved in teaching medical students, 
residents, and fellows (Table 2). Respondents employed by academic medical centers report teaching 
about 1.5 half-days/wk while clinical care providers, federal employees, and those in the 
pharmaceutical/biotech industry spend similar---0.4, 0.6 and 0.5 half days/wk---but, significantly less 
time (P < 0.01) teaching than counterparts in academe (Table 2). 
     Clinical care providers devote an average of 1.4 half-days/wk to investigative work. But, research 
studies occupy an average of 4.0 half-days/wk among rheumatologists in academic medical centers, and a 
respective 4.8 and 5.1 half days/wk for those employed in the federal and pharmaceutical/biotech sectors 
(Table 2). Administrative duties require an average of 0.8 half days/wk among clinical care providers, 1.5 
half days/wk in the academic and federal arenas, and about 3.8 half days/wk in the pharmaceutical/biotech 
industry (Table 2). 
Scope and scale of investigative activities. Analysis of the types of investigative work accomplished by 
rheumatologists, early in their careers, established that patient-oriented research is the predominant 
activity (P < 0.01) exceeding the commitment to either disease- or population-oriented research by 2.5-
fold (Table 3). Basic, translational, and prevention-oriented research each involved comparable levels of 
effort (P > 0.25), but the time devoted to these activities is only a fraction of 1 half-day/wk (Table 3) 
when these activities are examined independent of workplace. 
     Investigative work was accomplished by about 84% of respondents in the 12 mo preceding the survey 
(Table 3). Respondents pursued both basic and clinical research, but placed a premium (P < 0.001) on 
studies requiring human subjects (Table 3). No gender disparities are evident (P > 0.25) among the 
fraction of early career rheumatologists that report being uninvolved or involved in any of the 
investigative pursuits examined here (Table 3).  
     The workplace for investigative rheumatology was dissected by employment sector, namely: academic 
medical centers (AMC'), clinical practice settings, the federal government, and the pharmaceutical/biotech 
industry (Table 3). Within the clinical care workplace, research is pursued by about 69% of specialists 
albeit at percentages below those of rheumatologists employed in workplaces offering dedicated time for 
research (Table 3). The clinical care workplace emphasizes patient-oriented studies, primarily, and 
disease- and population-oriented research, secondarily (Table 5). Tertiary attention is given to basic, 
translational- and prevention-oriented research, but only token efforts are devoted to the later three 
activities (Table 3).  
     Workplaces sponsored by the federal government and the pharmaceutical/biotech industry engages in 
similar lines (P > 0.15) of investigative work (Table 3).  The investigative portfolio of the academic 
workplace differs from all other employment sectors because commitments are dispersed among multiple 
activities (Table 3).  For instance, patient- disease- and population-oriented research are the most 
prevalent activities, but the fraction of effort devoted to each activity is similar amounting to about 20%. 
Basic- and translation-oriented research explain 12% to14% of investigative work with a remaining 4% 
devoted to prevention-oriented research (Table 3). 
     The sources of money used to underwrite the salaries of early career respondents were assessed to 
establish the salary support for investigative work in rheumatology.  Clinical earnings are the primary 
source of funds used to defray the salaries of investigative rheumatologists, early in their careers, and 
account for about 39.7 % of the total dollars driving the investigative enterprise. Grant and contract 
funding, in contrast to clinical income, covered about 21.3 % of the salary costs for research studies. 
Intramural funding sources (medical schools/hospitals) finance about 14.5% of investigative labor costs 
while endowments and income from "other" sources cover about 8.3 % of research salary costs.  
Rheumatologists employed by the federal government and the pharmaceutical /biotech industry explain a 
respective 8.3 % and 7.9 % of the salary dollars supporting innovation and discovery in rheumatology. No 
gender differences are evident in the source of funds committed to underwrite the salaries of early career 
rheumatologists engaged in scholarly work (P > 0.25). 
     The submission of proposals and the receipt of grants by principal (PI) and co-principal investigators 
(Co-PI) are summarized in Table 4. A total of 53 early career rheumatologists produced 153 proposals for 
post-fellowship research training (Table 4). Approximately 13.1 % of post-fellowship training proposals 
were prepared to gain funding for an NIH K-08 mentored scientist award. An average of 1.8 K-08 
proposals were submitted per applicant with a success rate of 41.1% per respondent or 22.2 % per 
application (Table 4). Far fewer training proposals are submitted to the VA, in comparison to NIH, and 
the success of these proposals is about 20.0 % per respondent (Table 4). 
     Survey respondents produced over 300 proposals to obtain funding for research projects either as a PI 
or a Co-PI (Table 4). About one-third of investigator-initiated proposals were submitted to NIH, one-third 
to industry, and one-third to philanthropic sources (Table 4). Prospective PI's submitted an average of 2.8 
proposals to NIH, and received 2.0 awards per respondent for a success rate of 51.1 % per respondent or 
31.1% per application (Table 4).  Fewer proposals were submitted to non-NIH HHS agencies and the VA, 
but the mean success rate per respondent was greater (P < 0.05) than that reported for NIH awards (Table 
4). The success rate of PI produced proposals considered by philanthropic sources, industry, and other 
funding sources were a respective 42 %, 43%, and 50%  (Table 4). Co-PI proposals considered by federal 
and non-federal agencies achieved funding at about the same level (P > 0.15) as those submitted by PI's 
(Table 4). 
     We determined whether or not a correlation exists between a respondent's training at "research-
intensive" undergraduate institutions, medical schools, residency programs or fellowship programs and 
the receipt of research project grant awards either as a PI or Co-PI (Table 5). More specifically, we 
considered federal and total grants awarded to both PI's and Co-PI's as dependent variables in multiple 
regression analyses, while the explanatory variables included estimates of institutional "research-
intensity" at each of the four specific stages of the individual's training, as well as gender, years post-
fellowship, earning an advanced degree (M.S., M.P.H., Ph.D.), and the number of half-days/wk devoted 
to research. An additional model was used to estimate an average measure of respondent training at 
"research-intensive" institutions. Quite striking, multiple regression analysis indicated that only the 
number of half-days/wk devoted to research was related to grant award measures. The award of research 
project grants was unrelated to an individual's gender, years post-fellowship, earning an advanced degree 
(M.S., M.P.H., Ph.D.) or the "research-intensity" of institutions, at any of the four stages of the 
individual's training. All measures of "research-intensity," however, are positively correlated with the 
number of half-days/wk early career respondents dedicate to research when the explanatory variables are 
years post-fellowship and the "research-intensity" of institutions at which respondents are trained, (Table 
5). Put simply, the "research-intensity" of institutions---at each stage of an individual's training---is 
correlated with the number of half-days/wk devoted to research, which in turn is related to the number of 
research grants received by PI's and Co-PI's. 
     The receipt of an NIH K-08 award, however, is a consequential marker of research project grants 
awarded to both PI's and Co-PI's from federal and nonfederal sources (P < 0.001). Specifically, early 
career rheumatologists receiving a NIH K-08 award were estimated to receive an average of 2.8 and 1.2 
federal research project grants as respective PI's or Co-PI's.  
Fostering innovation and discovery in rheumatology. Respondents were queried about their interest in 
pursuing a career involving research when they were first year medical students, residents, and fellows. 
The fraction of positive responses (yes) increased linearly from about 28 % for medical students, 38 % for 
residents, and 60 % for fellows. The same cohort was asked to indicate whether opportunities to 
participate in a faculty-directed research project were well advertised when they were medical students, 
residents, and fellows. Approximately 75 % of respondents reported that mentored research projects were 
not well advertised when they were medical students and residents. But, only about 33 % of first-year 
fellows indicated they were unaware of opportunities to participate in a faculty-mentored research project. 
     Potential disincentives for pursuing an investigative career were examined to consider interventions for 
rebooting enthusiasm for clinical research (Table 6). Approximately 75 % of respondents perceived that 
clinical investigators are undercompensated relative to rheumatologists who place a premium on 
providing clinical care (P < 0.01). A greater number of respondents, 80 %, report that investigative 
careers are unattractive relative to those dominated by clinical service because of the expectation to 
produce publications and prepare proposals to gain funding for clinical or basic studies (P < 0.01).  About 
72 % of respondents noted that job security is a significantly greater risk for clinical investigators than for 
clinical care providers (P < 0.01). Interestingly, the time and intellectual energy required to pursue a 
successful career in clinical investigation was not perceived to be any more burdensome than that required 
for a successful career emphasizing clinical service (Table 6). 
     The perceived undercompensation of investigative rheumatologists reported in Table 6 was examined, 
in greater detail, by using a Tobit regression model that specified that the natural logarithm of pre-tax 
annual earnings as a function of two key explanatory variables – years post fellowship and half-days/week 
devoted to research – as well as variables to control for gender, type of employment, and total work hours 
per week. The results indicate that pre-tax annual earnings increased linearly at an average of 1.8 %/yr 
with each year of post fellowship experience (Fig. 1). Rheumatologists who devote 2 or more half-
days/wk to investigative work, in salient distinction, are undercompensated by about 2.3 %/yr for each 
half-day/wk spent on research (P < 0.01) relative to cohorts devoting1 half-day/wk or less on investigative 
work (Fig.2). 
Institutional commitments to investigative rheumatology. Institutional support for investigative 
rheumatology was estimated by using the total dollar value of start-up packages provided to 
rheumatologists, early in their careers, for personnel, equipment, supplies, and other research expenses. 
The results indicate a linear relationship between the number of half-days/wk devoted to research and 
institutional investments made to support the nascent research programs of rheumatologists early in their 
careers (Fig. 3). 
     The availability of tenure-track positions was estimated for the fraction of respondents employed in 
academic medical centers. Tenure opportunities are limited to about 50% of the institutions where early 
career rheumatologists are employed. An estimated 53.2 % of women and 46.8 % of men work at AMC's 
granting tenure. Approximately 40. 2 % of women and 59.5 % of men held tenure-eligible faculty 
appointments, a differential that was not significant (P > 0.12). 
 
DISCUSSION 
     The results of this study provide important new information about the workforce and workplace for 
rheumatology, and offer fresh insights about the scope and scale of clinical research in rheumatology.  
The findings also furnish a rational framework for designing interventions to enhance the investigative 
enterprise and ultimately transform the clinical practice of rheumatology.  
     The present assessment of rheumatologists, early in their careers, relied on self-reported responses to a 
Web-based questionnaire. Surveys provide the only logical mechanism to examine a workforce engaged 
in disparate activities, and assess workplaces that are decentralized across North America. The reliability 
of self-reported estimates of individual performance and personal experiences has been verified 
exhaustively (19). Tests of the credibility and validity of survey responses emphasize that conclusive data 
relies on multiple criteria (20), namely: i) asking clear and unambiguous questions, ii) limiting queries to 
information respondents readily know, iii) confining questions to recent events or well established 
routines, iv) restricting questions to those with high face and content value, and v) avoiding responses that 
threaten, violate privacy, or elicit professionally or socially desirable responses.  
     The Web-based questionnaire adopted for this study was designed to satisfy each of these conditions. 
Further, a prototype of the survey tool was sent to 18 rheumatologists meeting all of the criteria for 
participating in this study. This cohort was invited to take the survey, and provide written comments on 
any question that appeared troublesome, offensive, or ambiguous. The final version of the survey tool was 
amended to address the apprehensions of pilot test volunteers. Importantly, the gender mix, age 
distribution, location of states within the US, and country of residence of survey participants were 
comparable (P > 0.20) to the cohort of rheumatologists eligible to return a survey questionnaire. The 
concordance between expected and actual survey respondents offers assurance that the present findings 
typify the experiences of early career rheumatologists from Canada and the United States. It seems 
reasonable to assert, therefore, that the present survey protocol provides the framework to formulate 
meaningful insights about the experiences and training of rheumatologists, in general, and the cohort of 
rheumatologists engaged in innovation and discovery, in particular. 
     The results offer a contemporary snap shot of the fraction of time devoted to clinical service, teaching, 
research and administrative tasks among rheumatologists early in their careers. First, the number of half-
days/wk spent on each task is employer dependent (Table 2). Second, teaching and administrative 
responsibilities are accomplished within each of the four workplaces (Table 2). The half-days/wk devoted 
to these two tasks, however, are clearly secondary to either clinical service or research or both depending 
upon the particular work place. Third, the clinical service workplace is defined by a 75 % effort to patient 
care, a singular time commitment not evident in any other workplace (Table 2). Last, in other workplaces, 
time is dispersed among the four types of tasks with research emerging as the dominant activity, but only 
on the order of 39 % to 45 % effort (Table 2). Among the workplaces that champion clinical investigation, 
rheumatologists in the academic sector devote less time to research than colleagues affiliated with either 
the federal or pharmaceutical sectors (Table 2).  
     The finding that academic rheumatologists devote an average of 45 % effort to investigative work was 
unanticipated given that early career faculty are advised to spend about 75 % effort on research to develop 
their research program (21-22). The present results imply that opportunities to pursue investigative work 
are hampered by one or more of the following: institutional priorities, the need to generate earnings closer 
to those of full-time clinical providers through clinical service, life style preferences, and the unreliable or 
problematic support for clinical research that is available from grants and/or contracts awarded by federal 
agencies.  
     The type of investigative work pursued by rheumatologists, early in their careers, was defined by 
inviting respondents to specify their involvement in one or more of the following: basic-, translational-, 
disease-, patient-, population-, and prevention-oriented research. The findings offer new perspectives 
about the scope and scale of investigative work within each of these domains. The results document that 
human subjects are required for over 90% of the research pursued by rheumatologists, early in their 
careers (Table 3). It is critical to note that the survey tool advised respondents to distinguish between 
laboratory-based and clinical studies involving the use of human subjects known to the investigator 
(Table 3). Next, patient-oriented research is the predominant investigative activity pursued across all 
workplaces (Table 3). All workplaces focus comparable attention on disease- and population-oriented 
research. Both of these activities, however, are subordinate to patient-oriented work. The percent effort 
devoted to translational-, and basic-oriented research is analogous among workplaces, but the 
commitment to these two lines of work is only a fraction of that made to the other types of clinical studies 
considered here. Prevention research is the least prevalent activity with little or no effort reported for any 
workplace (Table 3). 
      The premium placed on patient- and disease-oriented studies in the clinical care workplace 
underscores the interest and opportunity of early career rheumatologists to direct clinical protocols or 
participate in multi-center clinical trials of new drugs and procedures sponsored by either federal agencies 
or the pharmaceutical/biotech industry or both. This assertion is based on two lines of evidence, namely: 
i) research is the second most prevalent activity among clinical care workforce, and ii) about 70% of the 
clinical care workforce participates in investigative work. These results, considered together, indicate that 
the provider workforce is a previously undocumented but formidable cadre of investigators who advance 
the clinical practice in rheumatology by fixing their attention primarily on patient- and disease-oriented 
research.      
     Research is the predominant commitment within workplaces supported by the federal government and 
the pharmaceutical/biotech industry, and both workplaces exploit similar investigative strategies (Table 
3). The primary distinction between the two workplaces resides in the commitment of the 
pharmaceutical/biotech industry to translational research, an effort exceeding that of all other workplaces 
(Table 3). Research in the academic workplace is best described as multi-focal where investigative 
attention is disbursed among all lines of work. Similarities in the scale of the investigative effort within 
the academic research enterprise emphasize its breadth in contrast to the programmatic specificity noted 
in each of the other workplaces (Table 3).  
     The inattention accorded to prevention research, across all workplaces, was unexpected given the suite 
of emergent technologies designed to estimate an individual’s risk for developing diseases, the 
opportunity to prevent disease onset, and the possibility of intervening at the earliest possible time when 
disease occurs (23-24). Contemporary investigative rheumatology is replete with strategies for exploiting 
the tools of genomic medicine---risk assessment, disease tracking, and personalized therapy---to prevent 
the chronic disabilities occasioned by connective tissue disorders (25-27). Federal and philanthropic 
stakeholders in rheumatology should view this clinical gap as an opportunity to developing a set of 
interventions aimed at targeting significant new monies for prevention-oriented research with the goal of 
stimulating interest in prevention-oriented work with the objective of transforming medical care for 
patients with rheumatoid diseases.  
     Analysis of the sources of money used to compensate early career rheumatologists for the fraction of 
time spent on research indicates that clinical earnings prevail as the chief source of funds with about 40 % 
of research salary costs paid through clinical service. Grant and contract funds, in sharp contrast, only 
cover about 20 % of the salary expenses for research. Medical schools and/or teaching hospitals 
underwrite about 12 % of the salary costs for doing investigative work, and about 7% is paid from other 
unspecified sources. Research salary subventions, awarded by medical schools/hospitals, are limited, and 
intended as short-term investments for launching the careers of new faculty or to provide bridge funding 
for established faculty who have temporarily lost salary support.     
     The present results indicate that clinical earnings play a critical role in supporting the investigative 
work of academic rheumatologists early in their careers. The need to rely of clinical income, as apposed 
to funding derived from to extramural grants or contracts, has several unintended consequences for 
investigative rheumatology, namely: i) innovation and discovery is hobbled by delaying or possibly 
preventing therapeutic advances for the clinical management of arthritis and other rheumatic conditions, 
ii) high reward studies involving contemporary technologies are abandoned or postponed delaying a shift 
in the paradigm from curative to preemptive rheumatology, and iii) basic scientists are unaware of 
technical gaps in clinical studies that must be overcome to develop new therapeutic and preventative 
strategies.  These unintended outcomes are traceable, in part, to an approximate disparity in funding of 
65:35 for basic versus clinical studies by federal agencies (28), and, in part, to a steadily evolving 
dysfunction in the federal-institutional partnership for clinical investigation recently detailed by Crowley 
et al. (29). 
     The analysis of research project proposals produced by early career rheumatologists offers important 
new information about the fraction of early career rheumatologists who compete for extramural research 
support as PI's or Co-PI's (Table 4). The findings establish that about 21% of early career respondents 
submit investigator-initiated research project applications for research projects to federal and non-federal 
agencies in approximately equivalent proportions (Table 4). The outcome of applications submitted by 
PI's and Co-PI's are decidedly successful as determined by the receipt of about 2.0 NIH research project 
grants for both PI's and Co-PI's during their early careers (Table 4). Finally, the results indicate that 
neither an advanced degree (M.S., M.P.H., Ph.D.) nor training at "research-intensive" institutions is 
correlated the receipt of grants from federal or nonfederal sources by either a PI or Co-PI (Table 5). 
Affiliation with "research-intensive" programs, however, is correlated (P < 0.001) with the number of 
half-days/wk devoted to investigative work (Table 5), a finding that is consistent with data documenting 
that more than 80 % of the early career workforce is committed to investigative work. 
     Proposals for post-fellowship research training were produced by about 20 % of respondents for 
consideration by federal, philanthropic, and industrial funding sources (Table 4). An estimated 13 % of 
respondents produced applications for NIH-K-08 mentored scientist awards with an approval rate of 41 % 
per respondent or about 22 % per individual application since an average of 1.8 applications is required to 
achieve funding (Table 4). The novel finding, based on assessing K-08 awardees, is the compelling 
association (P < 0.001) between receiving a NIH K-08 award and the subsequent award of an estimated 
2.8 NIH research project grants. This outcome provides the rationale for considering interventions that 
would encourage a fraction of physicians, from research-oriented backgrounds, to acquire preliminary 
evidence for submitting a K-08 application at the earliest possible stage of their careers. We must 
acknowledge, however, that the present study was not designed to control for all of the possible variables 
needed to predict the success of K-awardees as future recipients of federal research grants. Nevertheless, a 
demonstration project, involving a small number of rheumatologists---from research oriented programs---
seems justified to test whether or not participation in "research-intensive" programs is a causal factor in 
shaping the success of K-awardees as future recipients of federal research project grant awards. 
     Past support for K-08 awards by the National Institute of Arthritis Musculoskeletal and Skin Diseases 
(NIAMS) appears modest as judged by an average award rate of 7.7 applications per year made between 
1997-2005 for all subspecialty physicians supported by this institute (30). Based on the success of the K-
awardees noted here, it seem reasonable to suggest that NIAMS increase its investment in K-08 funded 
rheumatologists from about 4 % of the estimated 190 rheumatologists that seek post fellowship training 
per year to accommodate between 5% to 6% of the emerging crop of fellows or about 10 rheumatologists 
per year. Further, it may be sensible for the ACR to consider an intervention project designed to improve 
the success of initial K-08 applications by implementing a mechanism to vet first-time applications for 
NIH K-08 projects prior to formal submission. The goal of the proposed intervention is to eliminate both 
the wasted time and investigative inertia attending the resubmission of a revised K-08 application. The 
proposed intervention would compliment and extend ACR's ongoing initiative to award bridge funds and 
vet the revised applications of mid-career rheumatologists who seek to transition from a K-08 to a K-23 
award. 
     The time required to complete pre- and post-clinical training in rheumatology was examined to 
determine whether any significant gaps are evident in the education or training of early career 
rheumatologists. Women and men finished the prototypical 14-year training interval at similar ages and 
without any detectable delay (P > 0.25) starting with the onset of study for a baccalaureate degree and 
ending with the completion of fellowship training. These findings document the remarkable efficiency of 
programs for educating/training rheumatologists, and emphasize the abiding commitment made by 
rheumatologists to focus and finish their training assiduously. The temporal consistency observed in the 
education and training of rheumatologists suggests that a selected fraction of fellows interested in 
applying for NIH K-series awards should be encouraged to submit applications during the final year of 
fellowship training. This small but significant cohort of applicants would be positioned to receive a 5-year 
NIH-K-series award within 1 year or less after finishing a fellowship, or at about 35 yr of age. They world 
then be ready to apply for their first NIH R01 award at an average age of 39 yr, or about 5 years earlier 
than the reported mean of about 44 yr that is typical of physicians who were first-time recipients of NIH 
R-01 research project grants in 2008 (31). In this context, the results establish that there is ample room to 
improve the pipeline of prospective K-08 awardees by informing and encouraging medical students, 
residents, fellows to participate in faculty mentored research projects with an eye toward gaining the 
prerequisite experience and knowledge for producing a successful proposal for an NIH K-08 award. 
     Turning to disincentives for pursuing an investigative career, survey participants perceived a decided 
fiscal penalty for engaging in investigative work (Table 6). The reality of this perception was verified by 
showing that pre-tax annual earnings are reduced by 2.3 % for each half-day/wk devoted to investigative 
work among early career rheumatologists who spend 2 or more half-days/wk on research (Fig 2). The 
estimated fiscal burden for engaging in investigative work was determined by logistical multiple 
regression equations that controlled for gender, employer, total work time per week, and half-days/wk 
spent on research, and years post-fellowship so the findings would not be confounded by the significant 
fraction of early career respondents whose careers are just underway.  
     Other disincentives for pursuing investigative work focused on the declining availability of tenure-
track positions among academic employers, a finding that is consistent with an ongoing decrease in 
tenure-track appointments for clinical faculty within academic medical centers (32). The erosion in 
tenure-track positions in academic medical centers is tied to a perceived lack of job security when 
compared with employment as an owner/partner of a solo or group practice, or employment in a group 
practice, health system, or hospital. The overt concern with job security noted in the present survey is 
compelling and parallels the results of a recent report assessing the underperformance of clinical research 
in academic pulmonary medicine (33). Contemporary concerns with job security are not new, but remain 
among the most pernicious issues challenging medical schools since the heroic age of American medicine 
(34). Institutions seeking to recruit and retain the most talented clinical scholars should examine their 
history of job security and compensation to address the documented disincentives reported here by 
rheumatologists early in their careers. 
     The results demonstrate that the self-identified ethnic backgrounds of survey respondents approximate 
those of physicians graduating from allopathic medical schools in the United States between 1991-2005 
(Table 1). Two noteworthy disparities exist, however. First, the fraction of Black or African American 
rheumatologists detected in this survey is about 6% below the benchmark set by graduates of the nations 
medical schools (Table 1). Next, the percentage of rheumatologists who self-identify as Caucasian is 
approximately 6% above the mean for this cohort of graduates from US medical schools (Table 1).  
     The under representation of rheumatologists, from any ethnic background, is of intrinsic significance 
to investigative rheumatology.  This issue merits deliberate and resolute attention because the ethnic 
background of physicians directing clinical protocols shapes the ethnic profile of volunteers agreeing to 
participate in a clinical trial or study (35-37).  The acknowledged low rate of minority participation in 
clinical studies is exacerbated, in part, by the paucity of physicians from underrepresented ethnic groups 
who direct translational-, disease-, and patient-oriented research projects (35-36). The participation of 
underrepresented ethnic groups in clinical trials and studies is essential (35) since reliable estimates of the 
safety and efficacy of new and existing drugs or treatments are unachievable unless the participants in 
clinical trials mirror the demographic profile of the US population at large (35). Addressing racial/ethnic 
disparities in clinical trials in rheumatology is a persistent and evolving problem beyond the scope of this 
study (37). But, the need to reconcile ethnic disparities in the future workforce for rheumatology is an 
emergent concern pertinent to investigative rheumatology and the delivery of rheumatologic care to all 
demographic groups. Disparities in the ethnic backgrounds noted here point to the possibility of 
implementing interventions to recruit future generations of rheumatologists that approximate the 
demographic norm of graduates from the nations medical schools (18). The rationale behind the proposed 
intervention is consistent with the recommendations of several national efforts designed to facilitate the 
inclusion of all demographic groups within highly trained scientific workforces including those for 
medicine (38-40). 
     Several general principles are warranted based on the present analysis of the scope and scale of 
investigative work accomplished by rheumatologists early in their careers. First, women represent an 
increasing and nearly equivalent segment of the workforce for rheumatology (41-42). Importantly, the 
present assessment of the workforce and workplace failed to uncover any evidence of gender disparity.  
     Second, the results emphasize that the commitment of early career rheumatologists to clinical research 
is more robust than expected from databases maintained by professional organizations (43) or from 
estimates of NIH awards made to physicians whose clinical specialties and investigative work is 
undefined (44). The prevalence of investigative work accomplished, across all employment sectors, in 
rheumatology points to the importance of designing future studies to dissect both the workforce and 
workplace, rely on a broad assessment of investigative activities within all workplaces, and allow 
physicians to self-define their recent commitment to administrative, clinical, didactic, and investigative 
work.  
     Understanding the fraction of the workforce engaged in investigative rheumatology is of utmost 
importance because this cohort drives clinical progress, and ultimately shapes patient care by extending 
therapeutic options through the application of advances in diverse disciplines such as autoimmunity, 
inflammation, genetics, pharmacogenomics, and risk assessment. The significance of this "rare" cohort on 
rheumatology is profound, and far exceeds their numbers within the workforce since a single contribution 
offers the potential of benefiting thousands of patients by transforming the clinical management of a 
particular disease. It is no exaggeration to anticipate that the demand for innovation and discovery in 
rheumatology will remain robust given the growing incidence of musculoskeletal disease in an aging US 
population, and the emerging opportunities to achieve preemptive medical care (23). 
      Third, opportunities to achieve clinical innovation and discovery in rheumatology are increasing 
exponentially with the proliferation of clinical proteomic and biomarker technologies for the diagnosis 
and treatment of disease, monitoring patient responses to therapeutic agents, and even preempting certain 
arthritic and rheumatoid conditions (25-27). Rheumatology could well be at the forefront of developing, 
testing, and applying these emergent technologies with the ability to target particular subsets of patients 
with occult autoimmune conditions that are manifested as rheumatoid disease and are currently a 
challenge to treat and manage (45). All stakeholders within rheumatology--- academic, federal, industrial, 
philanthropic, professional---have the opportunity to accept the challenge and provide the leadership to 
promote prevention research as a core theme within investigative rheumatology. This action has the 
potential to reboot investigative rheumatology, and ultimately transform clinical practice from disease-
based medicine to prospective health care with personal health care planning (23).  
     Fourth, the results provide a succinct snap shot of contemporary challenges facing the federal-
institutional partnership for clinical investigation. On the one hand, extramural investigative partners are 
driven to devoting increased time to clinical service to generate clinical income for underwriting the cost 
of investigative work early in their careers. On the other hand, federal partners accede they have had 
persistent difficulty supporting clinical research (46), an acknowledgement that is consistent with 
documented disparities in funding of basic over clinical studies (29,47), achieving sapient integration of 
clinical research among agencies within the Department of Health and Human Services (29), and the lack 
of a palpable national commitment to transform medical practice from curative to preemptive over the 
approaching decade (48). These conclusions are not intended to detract from recent initiatives, 
championed by NIH (49,50), to improve the climate for clinical scholarship.  Simply put, this overview 
provides the template for initiating a national dialog designed to integrate the coordination and 
collaboration of future investigative strategies in rheumatology, and to develop a fundamentally new 
model for funding a future workforce prudently and amply to expand therapeutic and preventive options 
for an unfolding array of rheumatologic conditions affecting children and adults. Only then will a bright 
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Table 1. Self-identified ethnic backgrounds of rheumatologists, early in their careers, and  
 




      Self-identified backgrounds (mean %)*   Graduates of  
   US medical 
  schools (%)† 
   Women         Men              Both 
                           genders      
     
American Indian or 
Alaskan Native‡  
     ---        ---         ---           0.7 
     
Asian American     16.8        14.4                 15.5         16.9 
     
Black or African 
American 
      0.9          0.0          0.4           6.5 
     
Caucasian     72.9       76.5        74.9         68.7 
     
Hispanic or Latino 
American 
      5.6         6.1          5.9           6.4 
     
Multiethnic       1.9         0.8          1.3    Unreported 
     
Other: unknown or 
unreported§ 
 
      1.9         2.3           2.1           0.8 
 
     
 
*Each value is expressed as the percent of responses reported by a cohort of 239 early career 
rheumatologists consisting of 107 women and 132 men. 
† The ethnic backgrounds of U S medical school graduates was determined by estimating the mean 
number of individuals, within specified ethnic groups, that graduated from allopathic medical schools, 
each year, from1991 to 2005 (15). An average of 15,713 students graduated per year between 1991 and 
2005, the same 15-year sample window adopted for the present survey of rheumatologists early in their 
careers. 
‡ The number of American Indians and Alaskan Natives was not determined in this study, but are listed 
here to coincide with the demographic profiles of graduates from US medical schools (15). 
§ The fraction of individuals that self identified as  "other" may include rheumatologists from ethnicities 
(American Indian, Alaskan Native, Hawaiian Native, Pacific Islander) that were unlisted in the survey 
instrument for this study, or it may consist of individuals whose ethnicity is unknown or undisclosed. 
Table 2. Time commitments to clinical service, teaching, research, and administration  
 
among workplaces where early career rheumatologists are employed. 
 
   Activity                           Time commitments in half-days/wk (mean ± SEM)* 
                                                               (percent effort) 
    Clinical 
    care 
providers† 
   AMC 
  teaching   
  hospital‡ 




          
Clinical service  7.9 ± 0.2  
   (74.7) 
 3.5 ± 0.2        
   (34.9) 
     2.3 ± 0.4 
      (21.6) 
     1.5  ± 1.3 
       (13.6) 
          
Teaching¶  0.4 ± 0.1    
    (3.6) 
 1.3 ± 0.1 
   (11.9) 
     0.6 ± 0.2 
        (6.8) 
      0.5 ± 0.4 
        (4.5) 
          
Research  1.4 ± 0.1  
   (15.3) 
 4.1± 0.3 
  (38.7) 
     4.8 ± 0.9 
       (52.8) 
       5.1±0.9 
       (44.1) 
        
Administration∫  0.8 ± 0.1    
    (6.4) 
 1.5 ± 0.1 
  (14.5) 
     1.5 ± 0.3 
       (18.8) 
      3.8 ± 1.5 
       (37.8) 
     
  Totals 10.5 ± 0.1 10.4 ± 0.2      9.2 ± 0.3     10.9 ± 0.7 
 
* Each value is expressed as the mean ± standard error of the number of half-days/wk reported by 
respondents for each of the designated activities. The numbers in parenthesis are expressed as the percent 
effort within each workplace to facilitate comparisons among workplaces. Respondents were asked to 
specify the half days/wk devoted to each of the indicated activities during the 12 mo preceding the survey 
based on the time they negotiated with their supervisors. The results provide an estimate of the time/effort 
reported for a putative 40 hr workweek since respondents were advised to exclude "off the clock" 
commitments for any activity that might be accomplished after normal working hours or on weekends, 
holidays or vacation periods. Note that the "total" half-days/wk deviates from the expected value of 10; 
the values were not normalized to 40 hr/wk to allow the data to reflect the actual values reported for each 
workplace.   
†Clinical care providers refer to rheumatologists who deliver clinical care as an owner/partner of a solo or 
group practice, or are employed by a group practice, health system, or hospital. 
‡AMC: academic medical center. 
§Federal government: includes all rheumatologists employed by the Department of Health and Human 
Services (HHS), Department of Defense (DOD), and the Department of Veterans Affairs (VA). 
¶Includes the total time devoted to teaching of medical students, residents, and fellows. 
∫Includes the total time devoted to administrative work including committee assignments. 
 
Table 3.  Assessment of the investigative activities pursued by rheumatologists early in their careers, and the effect of workplace and/or 
employer on the type of investigative work accomplished by rheumatologists.  
 
Investigative activity 
pursued in past 12 
mo.* 
              Gender   Both 
genders 
  Investigative 
  commitment 
  half-days/wk 
 (mean ± SEM) 
                       Workplace and/or employer (mean %) 
  Women    Men  Clinical care 
   provider† 
      Federal 
   government 
HHS/DOD/VA‡ 
  Pharma or 
    biotech 
   industry 
Academic             
  medical     
   centers§  (mean %) (mean %) (mean %) 
     
None     17.6    15.3    16.3          ------       40.7          9.1         6.3      10.0 
         
Basic       8.3    10.3      9.6     0.82  ±  0.15         1.9          9.1       12.5      13.7 
         
Translational       6.3      9.7      8.3     0.50  ±  0.10         1.9          9.1       18.8      11.6 
         
Disease-oriented     16.4    17.1    16.8     1.30  ±  0.16         9.3        22.7       18.8      19.5 
         
Patient-oriented     32.1    31.5    31.7     3.46  ±  0.27       36.4        40.9       37.5      21.6 
         
Population-oriented     15.7    12.0    13.6     1.12  ±  0.16         6.8          9.1         6.3      19.5 
         
Prevention-oriented       3.1      4.2      3.7     0.31  ±  0.10         3.1           0          0         4.2 
 
The results are based on a sample of 244 rheumatologists consisting of 113 women and 131 men. The type of investigative activities pursued by women and men did not 
differ (P > 0.25). 
*Note, respondents were allowed to specify one or more of the designated activities to reflect the types of investigative work they pursued in the 12 mo preceding the 
survey. Investigative activities were defined as follows in the survey tool: Basic research: laboratory-based research involving the development of new drugs, technologies, 
or devices. Translational research: bench to bedside or bi-directional research involving human subjects known to the investigator. Excludes use of human specimens 
(cells/tissues) for laboratory studies. Disease-oriented research: requires use of human subjects to investigate the mechanisms or natural history of disease, or improve the 
detection or diagnosis of disease. Patient-oriented research: clinical trials, including Phase I, II, III, IV trials of drugs, biologics, devices, and the evaluation of therapeutic 
interventions. Population-oriented research: outcomes studies of populations, health services and cost effectiveness research, studies of health quality including best 
practices and medical errors, epidemiology and genetic studies, and community-based clinical trials. Prevention-oriented research: primary and secondary prevention of 
disease in patients, and health promotion via behavioral modification. 
† Clinical care providers refer to early career rheumatologists who deliver clinical services as an owner/partner of a solo or group practice, or are employed by a group 
practice, health system, or hospital. 
‡Federal government: includes all early career rheumatologists employed by the Department of Health and Human Services (HHS), Department of Defense (DOD), and the 
Department of Veterans Affairs (VA). 
§Academic medical centers refer to any medical school or teaching hospital accredited to sponsor a residency program in internal medicine or pediatrics, or a fellowship 
program in adult or pediatric rheumatology or both as approved by the Accreditation Council for Graduate Medical Education <http://www.acgme.org>. 
Table 4. Analysis of proposals submitted and awards received by rheumatologists, early in their careers, for post fellowship research  
 
training and research project grants. 
 
Type of proposal or   
      grant award 
                              Sources of funding available to rheumatologists 
                     HHS*        VA*       DOD* Philanthropy    Industry     Other 
        NIH†         Other HHS†         
                  
Training (post 
fellowship) 
              
   Proposals/respondent‡    1.8 ± 0.3          0    1.4 ± 0.2         0    1.8  ± 0.2    2.6 ± 0.8    1.6 ± 0.2 
                  
   Success/respondent (%)       41.2        ---       20.0        ---         NA§         NA         NA 
               
Research as PI               
   Proposals/respondent‡    2.8 ± 0.4    0.9 ± 0.5    1.1 ± 0.6    1.5 ± 0.5     2.7 ± 0.3    2.9 ± 0.5    1.8 ±  0.3 
               
   Grants /respondent‡    2.0 ± 0.3    1.3 ± 0.3    1.0 ± 0.1         0     2.4 ± 0.3    2.3 ± 0.4    2.0 ± 0.7 
               
   Success/respondent (%)       51.1      80.0       100         ---       42.2        43.8      50.0 
              
Research as Co-PI              
   Proposals/respondent‡   2.4 ± 0.4   1.1  ± 0.9         0        0    2.1  ± 0.6    2.3 ± 0.7    4.3 ± 2.3 
              
   Grants /respondent‡   1.9  ± 0.4   0.6 ±  0.5         0         0    1.4  ± 0.7    2.0 ± 0.7    1.7 ± 0.9 
              
   Success/respondent (%)      45.8      75.0         ---         ---       50.0       41.6       40.0 
 
* Federal departments: HHS-Department of Health and Human Services, VA-Veterans Affairs, DOD-Department of Defense. 
† NIH- National Institutes of Health, Other HHS: AHRQ- Agency for Healthcare Research & Quality, CDC- Centers for Disease Control & Prevention FDA- Food & Drug 
Administration, HRSA- Health Resources & Services Administration, and SAMSA-Substance Abuse & Mental Health Services Administration. 
‡ Each value is expressed as the mean ± the standard error of the mean or the mean percent. Estimates of proposals submitted for post-fellowship training are based on a 
cohort of 51 applicants who produced 153 proposals from a sample of 247 rheumatologists. Estimates of proposals submitted for research project grants by PI's are based on 
a cohort of 38 applicants that submitted 233 proposals from a sample of 247 rheumatologists. Estimates of proposals submitted for research project grants by Co-PI's are 
based on a cohort of 17 applicants who submitted 86 proposals from a sample of 247 rheumatologists. 
§ NA: data not available.
Table 5. The correlation between time dedicated to research and gender, years post-fellowship, and the "research intensity"  
of institutions involved in the pre- and post-clinical training of early career rheumatologists. 
 
Explanatory variables*                                                           Regression model†  
          1         2          3         4         5         6 
        
Gender  0.01 ± 0.30   0.22 ± 0.29 0.03 ± 0.29 0.07 ± 0.29 0.01 ± 0.29  0.10 ± 0.29 
        
Years post fellowship -0.05 ± 0.02* -0.06 ± 0.02* -0.05 ± 0.02* -0.05 ± 0.02* -0.04 ± 0.02 -0.04 ± 0.02 
        
Baccalaureate institution 0.034 ± 0.10***      
        
Medical school  0.26 ± 0.06***     
        
Residency program   0.23 ± 0.04***    
        
Fellowship program    0.28 ±  0.05***   
        
Summed score     0.59 ± 0.11***  
        
Ph.D. program      0.14 ± 0.32 
 
*Time dedicated to research, the dependent variable, was determined from respondents reports of the number of half-days/wk devoted to 
research. The explanatory or independent variables included gender, years post-fellowship and the "research intensity" of institutions 
(estimated on a scale from 10 to 1 where 10 is best as noted in the Materials and Methods) respondents attended for their baccalaureate degree, 
medical degree, residency, fellowship, and Ph.D. when appropriate. A summed score was determined by adding the scores determined for 
baccalaureate institutions, medical schools, residency, and fellowship programs to provide an overall estimate of "research intensity."  
†Each value is expressed as a regression coefficient ± standard error of the mean. The level of significance is designated, where appropriate, as: 
P < 0.05*, P < 0.01**,  and P < 0.001***.
 Table 6. Perceived disincentives for pursuing an investigative career 
 
 among rheumatologists early in  their careers. 
 
    Tested disincentive for pursuing an      
             investigative career 
        Mean % * 
Agree Disagree 
   
Clinical researchers are under compensated 
relative to colleagues who devote most of their 
professional activity to providing clinical 
services. 
 
  75.6    24.4 
   
Faculty positions in medical schools or teaching 
hospitals are unattractive relative to private 
practice because of the expectation to obtain 
research grants/contracts and produce 
publications. 
 
   80.1   19.9 
   
The time and intellectual energy required for a 
successful career as a clinical investigator is 
simply too burdensome compared with that 
required for a successful career involving clinical 
service. 
 
  53.9   46.1 
Job security for clinical researchers in a medical 
school or teaching hospital is too risky compared 
with that of rheumatologists who focus on 
providing clinical service. 
 




*Each value is expressed as the mean percent of responses provided 
 
 for each question. The responses to each question are based on replies 
 
 from 244 rheumatologists.  
 
 
 Fig. 1.  The relationship between years post fellowship and the natural log of pre-tax annual 
earnings is described by the equation/linear function derived from a Tobit regression model. The 
model controlled for gender, employer, total work time/wk, half-days/wk spent on research, and 
for bias occasioned by missing observations. The equation predicts that the average annual pre-tax 
earnings of rheumatologists, early in their careers, increased by about 1.8 %/year of post 
fellowship experience. 
 
Fig. 2. The relationship between half-days/wk devoted to investigative work and the natural log of 
pre-tax annual earnings is described by the equation/linear function derived from a Tobit 
regression model. The model controlled for gender, employer, total work time/wk, half-days/wk 
spent on research, and for bias occasioned by missing observations. The equation, based on the 
cohort of rheumatologists spending 2 or more half-days/wk on investigative work, predicts that the 
average annual pre-tax earnings of rheumatologists, early in their careers, decreases by about 2.3% 















































































HALF-DAYS/WK DEVOTED TO INVESTIGATIVE WORK
y = -0.023*x + 11.59
 Fig. 3. Institutional investments in investigative rheumatology were estimated by considering the 
relationship between the number of half-days/wk devoted to research and the mean value of start-
up packages (total institutional dollars for personnel, equipment, supplies, and other research 
expenses) provided to rheumatologists employed by academic medical centers and/or teaching 
hospitals. Each bar designates the mean ± standard error of the mean of dollars invested in 
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